Evaluation of Tetrix Cream as a Protective Barrier Against Injurious Materials

To determine if Tetrix Cream,, when applied to the skin, acts as a barrier to prevent injury to the skin

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy

Age range

18 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Dermatolgoy Specialists, LLC

Louisville, Kentucky, 40202, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Normal subjects who are sensitized to nickel, neomycin, or fragrance mix.

Exclusion criteria

Under 18 years of age.

Treatment and study plan

Tetrix

Device

Twice daily topical application

Primary outcomes

Prevention of delayed bype hypersensitivity reaction following application of antigen

Time frame: up to 96 hours after antigen application

Sponsors and collaborators

Lead sponsor

Coria Laboratories, Ltd.

Industry

Registry information

Official study title

A Study to Determine the Skin Barrier Effect of Tetrix Cream

Important dates

Study start: 2007
Primary completion: 2007
Study completion: 2007
First posted: Mar 26, 2008
Registry last updated: May 22, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed